Cargando…

Silibinin Augments the Antifibrotic Effect of Valsartan Through Inactivation of TGF-β1 Signaling in Kidney

BACKGROUND: Chronic kidney disease (CKD) has become a major public health issue. Meanwhile, renal fibrosis caused by diabetic nephropathy can lead to CKD, regardless of the initial injury. It has been previously reported that silibinin or valsartan could relieve the severity of renal fibrosis. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ronggui, Wang, Qinqin, Ding, Zhaoyan, Zhang, Xiaojuan, Li, Yunping, Zang, Yichen, Zhang, Guijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026148/ https://www.ncbi.nlm.nih.gov/pubmed/32103902 http://dx.doi.org/10.2147/DDDT.S224308

Ejemplares similares

Comparison of digital subtraction angiography and contrast-enhanced ultrasound in assessment of carotid stenosis
por: Liu, Ronggui, et al.
Publicado: (2020)

Galunisertib Exerts Antifibrotic Effects on TGF-β-Induced Fibroproliferative Dermal Fibroblasts
por: Peterson, Joshua M., et al.
Publicado: (2022)

Antifibrotic function of cGKI in the kidney
por: Schlossmann, Jens, et al.
Publicado: (2015)

Antifibrotic effect of methylated quercetin derivatives on TGFβ-induced hepatic stellate cells
por: Ganbold, Munkhzul, et al.
Publicado: (2019)

Antifibrotic effects of eupatilin on TGF-β1-treated human vocal fold fibroblasts
por: Park, Sung Joon, et al.
Publicado: (2021)

Parameters for Contrast-Enhanced Ultrasound (CEUS) of Enlarged Superficial Lymph Nodes for the Evaluation of Therapeutic Response in Lymphoma: A Preliminary Study
por: Xin, Lei, et al.
Publicado: (2017)

Enhanced antiviral and antifibrotic effects of short hairpin RNAs targeting HBV and TGF-β in HBV-persistent mice
por: Ye, Lei, et al.
Publicado: (2017)

AT-MSCs Antifibrotic Activity is Improved by Eugenol through Modulation of TGF-β/Smad Signaling Pathway in Rats
por: Fathy, Moustafa, et al.
Publicado: (2020)

Antifibrotics in India
por: Dhar, Raja
Publicado: (2019)

Silibinin Prevents TGFβ-Induced EMT of RPE in Proliferative Vitreoretinopathy by Inhibiting Stat3 and Smad3 Phosphorylation
por: Ma, Xinqi, et al.
Publicado: (2023)

Silibinin: an old drug for hematological disorders
por: Zou, Hai, et al.
Publicado: (2017)

Author Correction: Enhanced antiviral and antifibrotic effects of short hairpin RNAs targeting HBV and TGF-β in HBV-persistent mice
por: Ye, Lei, et al.
Publicado: (2018)

Assessment of the effect of potential antifibrotic compounds on total and αVβ6 integrin‐mediated TGF‐β activation
por: Porte, Joanne, et al.
Publicado: (2014)

The Elusive Antifibrotic Macrophage
por: Adhyatmika, Adhyatmika, et al.
Publicado: (2015)

hTERT peptide fragment GV1001 demonstrates radioprotective and antifibrotic effects through suppression of TGF-β signaling
por: Chen, Wei, et al.
Publicado: (2018)

Combination of esomeprazole and pirfenidone enhances antifibrotic efficacy in vitro and in a mouse model of TGFβ-induced lung fibrosis
por: Ebrahimpour, Afshin, et al.
Publicado: (2022)

Antifibrotic Soluble Thy-1 Correlates with Renal Dysfunction in Chronic Kidney Disease
por: Saalbach, Anja, et al.
Publicado: (2023)

The evolution of natriuretic peptide augmentation in management of heart failure and the role of sacubitril/valsartan
por: Yandrapalli, Srikanth, et al.
Publicado: (2017)

Wound Healing Activity of Silibinin in Mice
por: Samanta, Rojalini, et al.
Publicado: (2016)

Silibinin and non-melanoma skin cancers
por: Prasad, Ram Raj, et al.
Publicado: (2020)

Inhibition of Phagocytosis by Silibinin in Mouse Macrophages
por: Sun, Kyung-Hoon, et al.
Publicado: (2023)

Antifibrotic Roles of RAAS Blockers: Update
por: Zhang, Ying-Ying, et al.
Publicado: (2019)

To compare anti-albumin urea effects of valsartan alone with combination of valsartan and amlodipine in patients of chronic kidney disease
por: Ameen,, et al.
Publicado: (2016)

Silibinin inhibits migration and invasion of the rhabdoid tumor G401 cell line via inactivation of the PI3K/Akt signaling pathway
por: Li, Yumei, et al.
Publicado: (2017)

Deciphering the Antifibrotic Property of Metformin
por: Septembre-Malaterre, Axelle, et al.
Publicado: (2022)

Efficacies of Controlling Morning Blood Pressure and Protecting the Kidneys by Treatment With Valsartan and Nifedipine CR or Valsartan and Amlodipine (MONICA Study)
por: Tanaka, Tohru, et al.
Publicado: (2013)

Silibinin Effect on Methotrexate-Induced Hepatotoxicity in Rats
por: Yanaşoğlu, Emine, et al.
Publicado: (2022)

TGF-β receptor inhibitor LY2109761 enhances the radiosensitivity of gastric cancer by inactivating the TGF-β/SMAD4 signaling pathway
por: Yang, Tian, et al.
Publicado: (2019)

The association of ACE gene polymorphism with diabetic kidney disease and renoprotective efficacy of valsartan
por: Wang, Yuying, et al.
Publicado: (2016)

Silibinin Inhibits NSCLC Metastasis by Targeting the EGFR/LOX Pathway
por: Hou, Xiaoying, et al.
Publicado: (2018)

Silibinin Attenuates Experimental Periodontitis by Downregulation of Inflammation and Oxidative Stress
por: Li, Xumin, et al.
Publicado: (2023)

NRF2 Activation Inhibits Both TGF-β1- and IL-13-Mediated Periostin Expression in Fibroblasts: Benefit of Cinnamaldehyde for Antifibrotic Treatment
por: Mitamura, Yasutaka, et al.
Publicado: (2018)

The involvement of TGF-β1 /FAK/α-SMA pathway in the antifibrotic impact of rice bran oil on thioacetamide-induced liver fibrosis in rats
por: Abdel-Rahman, Rehab F., et al.
Publicado: (2021)

Enhanced asthma-related fibroblast to myofibroblast transition is the result of profibrotic TGF-β/Smad2/3 pathway intensification and antifibrotic TGF-β/Smad1/5/(8)9 pathway impairment
por: Wnuk, Dawid, et al.
Publicado: (2020)

Caveolin-1 regulation of Sp1 controls production of the antifibrotic protein follistatin in kidney mesangial cells
por: Mehta, Neel, et al.
Publicado: (2019)

Antifibrotic Activity of Acylated and Unacylated Ghrelin
por: Angelino, Elia, et al.
Publicado: (2015)

ANTIFIBROTIC THERAPY IN IDIOPATHIC PULMONARY FIBROSIS
por: Scullion, T., et al.
Publicado: (2017)

Antifibrotic therapies to control cardiac fibrosis
por: Fan, Zhaobo, et al.
Publicado: (2016)

Antifibrotic therapy to normalize the tumor microenvironment
por: Hauge, Anette, et al.
Publicado: (2020)

Antifibrotic Therapies: Will We Ever Get There?
por: Thompson, Alexander James, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_m250a87rsmh6uke9dt4mbv7om6